Angioplasty Balloons Market Is Set to Reach US$ 4.2 Billion by 2033

The global Angioplasty Balloons market is expected to reach a value of US $ 4.2 Billion by the end of 2033 and is forecasted to expand at a CAGR of 3.4% during the forecast period of 2023 to 2033.

Angioplasty balloons are medical devices that are inserted into the blood vessels of the body to open blocked veins and arteries. They work by using a balloon to enlarge the artery or vein, which then allows blood to flow more freely. After surgery, the blood arteries are opened by blowing up the balloon to flatten the plaque against their walls, allowing normal blood flow to resume.

𝗚𝗲𝘁 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=S&rep_id=4318?PJ

Those who are obese and have high cholesterol levels are also increasing the market's potential. Technology developments, such as the emergence of innovative variants that may be implanted without requiring general anaesthesia and the development of imaging technologies, are other key growth-promoting factors.

𝗞𝗲𝘆 𝗗𝗿𝗶𝘃𝗶𝗻𝗴 𝗙𝗼𝗿𝗰𝗲𝘀 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗚𝗿𝗼𝘄𝘁𝗵

Various geographies such as North America has a high prevalence of cardiovascular diseases, such as coronary artery disease, which often require angioplasty procedures. The growing incidence of these diseases is driving the demand for angioplasty balloons.

The regional market is expected to occupy a 40% share of the revenue of the global angioplasty balloons market in North America. Increasing awareness of treatment options and the rising prevalence of cardiovascular illnesses are supporting market growth.

Continuous advancements in angioplasty balloon technologies, including drug-coated balloons and bioresorbable balloons, are enhancing the effectiveness and safety of angioplasty procedures. These technological innovations are driving the market growth.

Angioplasty balloons offer a minimally invasive approach to treating blocked arteries compared to traditional surgical procedures. With a growing preference for minimally invasive interventions among patients and healthcare providers, the demand for angioplasty balloons is increasing.

The aging population in North America is susceptible to cardiovascular diseases due to age-related factors. The increasing geriatric population is driving the demand for angioplasty procedures and, consequently, angioplasty balloons. The presence of favorable reimbursement policies for angioplasty procedures encourages patients to opt for these interventions. This factor plays a crucial role in driving the growth of the angioplasty balloons market.

𝗩𝗶𝘁𝗮𝗹 𝗜𝗻𝗱𝗶𝗰𝗮𝘁𝗼𝗿𝘀 𝗦𝗵𝗮𝗽𝗶𝗻𝗴 𝗙𝘂𝘁𝘂𝗿𝗲 𝗢𝗳 𝗧𝗵𝗲 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆

Continued advancements in angioplasty balloon technologies, such as drug-coated balloons, bioresorbable balloons, and cutting-edge materials, will drive the future of the market. Innovations that improve safety, efficacy, and long-term outcomes will be crucial in shaping the market landscape.

The healthcare industry is undergoing a shift towards value-based care, focusing on patient outcomes and cost-effectiveness. The future of the angioplasty balloons market will be influenced by the ability of these devices to demonstrate improved patient outcomes, reduced revascularization rates, and cost savings in comparison to alternative treatment options.

The growth of the angioplasty balloons market in North America will be influenced by emerging markets and demographic trends. The increasing aging population, rising prevalence of cardiovascular diseases, and improving healthcare infrastructure in emerging economies within North America will contribute to market expansion.

The regulatory landscape, including guidelines and approvals set by regulatory bodies such as the FDA and Health Canada, will play a significant role in shaping the future of the angioplasty balloons market. Stringent regulations focused on safety and efficacy, as well as expedited approval pathways for innovative technologies, will influence market dynamics.

𝗞𝗲𝘆 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗣𝗿𝗼𝗳𝗶𝗹𝗲𝗱 𝗶𝗻 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁

Medtronic plc
Cook Medical
Becton, Dickinson and Company
Biotronik
Boston Scientific Corporation
AngioDynamics
B. Braun
Cordis
Abbott Laboratories
Endocor GmbH
Infinity Angioblast Balloon
Johnson & Johnson
Koninklijke Philips N.V.
Merit Medical Systems, Inc.
Oscor Inc.
Terumo Corporation

𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗛𝗶𝗻𝗱𝗲𝗿𝗶𝗻𝗴 𝗧𝗵𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗚𝗿𝗼𝘄𝘁𝗵

Angioplasty procedures can be costly, including the cost of the angioplasty balloons and other associated medical devices. The high cost of these procedures may limit their accessibility, particularly for patients without adequate insurance coverage or financial resources.

The regulatory requirements for medical devices, including angioplasty balloons, can be stringent and time-consuming. Obtaining regulatory approvals from bodies like the FDA in the United States can involve lengthy and complex processes, which can delay the market entry of new products.

𝗛𝗼𝘄 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝗼𝗻 𝗶𝗻𝗳𝗹𝘂𝗲𝗻𝗰𝗲𝘀 𝘁𝗵𝗲 𝗺𝗮𝗿𝗸𝗲𝘁

Key market players are focusing on the improvement of product offerings by incorporating advanced technologies to be aligned with the common trend of value-based healthcare.

Competition encourages medical device manufacturers to invest in research and development to innovate and improve their angioplasty balloon products. Companies strive to develop advanced technologies, such as drug-coated balloons or bioresorbable balloons, to gain a competitive edge.

In 2022, GIE Medical initiated clinical trials in the US to launch ProTract X3 TTS Drug-Coated Balloon Technology to treat intestinal structures.

𝗞𝗲𝘆 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 𝗼𝗳 𝗔𝗻𝗴𝗶𝗼𝗽𝗹𝗮𝘀𝘁𝘆 𝗕𝗮𝗹𝗹𝗼𝗼𝗻𝘀 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗿𝗲𝗽𝗼𝗿𝘁

𝗕𝘆 𝗕𝗮𝗹𝗹𝗼𝗼𝗻 𝗧𝘆𝗽𝗲:
Normal
Drug-coated
Cutting
Scoring

𝗕𝘆 𝗠𝗮𝘁𝗲𝗿𝗶𝗮𝗹:
Non-compliant
Semi-compliant

𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻:
Coronary Angioplasty
Peripheral Angioplasty

𝗕𝘆 𝗘𝗻𝗱 𝗨𝘀𝗲𝗿:
Hospitals
Specialty Clinics
Catheterization Laboratories
Ambulatory Surgical Centers
Others

𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4318?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.